
    
      The BALTIMORE conditioning regiment will be used in this study with peripheral stem cell
      transplantation and fludarabine will be replaced by clofarabine for myeloid diseases (Acute
      Myeloide Leukemia, Myelodysplasia , myelofibrosis, Chronic Myeoloid Leukemia..) because of
      better antitumoral activity in this setting.
    
  